A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
索拉非尼和尼洛替尼联合使用可减缓去势抵抗性前列腺癌的生长
期刊:International Journal of Nanomedicine
影响因子:6.6
doi:10.2147/IJN.S97286
Monica Archibald, Tara Pritchard, Hayley Nehoff, Rhonda J Rosengren, Khaled Greish, Sebastien Taurin